CoCites: A citation-based method for searching scientific literature

Jeffrey M Witkin, Anna E Martin, Lalit K Golani, Nina Z Xu, Jodi L Smith. Adv Pharmacol 2019
Times Cited: 34

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz, Patrick J McGrath, Jerrold F Rosenbaum, Harold A Sackeim, David J Kupfer, James Luther, Maurizio Fava. Am J Psychiatry 2006
Times Cited: 3005

List of shared articles

Times cited

Repurposing of Drugs-The Ketamine Story.
Joydip Das. J Med Chem 2020

Novel drug developmental strategies for treatment-resistant depression.
Éva Borbély, Mária Simon, Eberhard Fuchs, Ove Wiborg, Boldizsár Czéh, Zsuzsanna Helyes. Br J Pharmacol 2022

Craving and addictive potential of esketamine as side effects?
Laura Orsolini, Virginio Salvi, Umberto Volpe. Expert Opin Drug Saf 2022

Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.
Ya-Ting Wang, Xiao-Le Wang, Si-Tong Feng, Nai-Hong Chen, Zhen-Zhen Wang, Yi Zhang. Pharmacol Res 2021

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.
Hitoshi Sakurai, Kengo Yonezawa, Hideaki Tani, Masaru Mimura, Michael Bauer, Hiroyuki Uchida. Pharmacopsychiatry 2022

Involvement of muscarinic receptor mechanisms in antidepressant drug action.
Jeffrey M Witkin, Jodi L Smith, Lalit K Golani, Emily A Brooks, Anna E Martin. Adv Pharmacol 2020

Chaperone Sigma1R and Antidepressant Effect.
Mikhail V Voronin, Yulia V Vakhitova, Sergei B Seredenin. Int J Mol Sci 2020